| Literature DB >> 31435378 |
Izzaddinn E Ahmed1, Hyder O Mirghani1, Mohammed A Mesaik2, Yassin M Ibrahim3, Tehreen Q Amin4.
Abstract
OBJECTIVES: The date fruit has been shown to possess several health benefits. This study aims to determine the effects of date fruit consumption on the onset and progression of labour.Entities:
Keywords: Date fruit; Delivery; Labour outcomes; Labour progression; Rutab
Year: 2018 PMID: 31435378 PMCID: PMC6695006 DOI: 10.1016/j.jtumed.2018.11.003
Source DB: PubMed Journal: J Taibah Univ Med Sci ISSN: 1658-3612
Basic and clinical characteristics of the study groups.
| Characteristics | Frequency (n) | Percentage (%) |
|---|---|---|
| Parity | ||
| Primigravida | 21 | 23.86 |
| Multipara | 61 | 69.32 |
| Grand multipara | 6.0 | 6.82 |
| Poor obstetrical history | 5 | 6.17 |
| Tocometry (performed) | 82 | 97.62 |
| Tocometry type | ||
| Continuous | 45 | 56.96 |
| Periodic | 34 | 43.04 |
| Tocometric findings | ||
| Normal | 71 | 93.42 |
| Suspicious | 5.0 | 6.58 |
| Pathological | 0.0 | 0.00 |
| Uterine contraction strength | ||
| Good | 27 | 44.26 |
| Moderate | 27 | 44.26 |
| Poor | 7.0 | 11.48 |
| Uterine contraction regularity | ||
| Regular | 20 | 64.52 |
| Irregular | 11 | 35.48 |
| Maternal temperature progression | ||
| Normal | 85 | 100 |
| Abnormal | 0.0 | 0.00 |
| Maternal blood pressure progression | ||
| Normal | 84 | 98.82 |
| Abnormal | 1.0 | 1.18 |
| Maternal heart rate progression | ||
| Normal | 84 | 98.82 |
| Abnormal | 1.0 | 1.18 |
| Maternal blood sugar level progression | ||
| Normal | 85 | 100 |
| Abnormal | 0.0 | 0.0 |
| Postpartum haemorrhage | 8.0 | 9.52 |
| Labour onset time/shift | ||
| Shift 1 (morning) | 53 | 60.23 |
| Shift 2 (evening) | 35 | 39.77 |
| Fluids used during labour | ||
| Ringer's lactate | 31 | 51.67 |
| Dextrose 5% | 18 | 30.0 |
| Dextrose 10% | 2 | 3.33 |
| Normal saline | 3 | 5.0 |
| Dextrose 5% in normal saline | 1 | 1.67 |
| Not given | 5 | 8.33 |
| Labour pain intensity | ||
| Mild | 16 | 21.05 |
| Moderate | 42 | 55.26 |
| Severe | 18 | 23.68 |
| Physical exercises at the latest gestational weeks | ||
| Performed | 4 | 6.35 |
| Not performed | 59 | 93.65 |
Labour progression and foetal outcomes in the study groups.
| Factors | Date fruit consumers | Date fruit with water consumers | Controls |
|---|---|---|---|
| Cervical dilatation (hour 0) | |||
| Min–max | 0–7 | 0–7 | 0–9 |
| Mean ± SD | 4.04 ± 1.940–9 | 4.23 ± 1.60 | 3.97 ± 2.43 |
| Median ± IQR | 4.0 ± 1.75 | 4 ± 2 | 4 ± 3 |
| Cervical dilatation (hour 1) | |||
| Min–max | 0–10 | 0–10 | 1–10 |
| Mean ± SD | 5 ± 2.47 | 5.63 ± 2.71 | 5.07 ± 2.45 |
| Median ± IQR | 5 ± 2 | 5 ± 3 | 5 ± 3.25 |
| Cervical dilatation (hour 2) | |||
| Min–max | 0–10 | 0–10 | 1–10 |
| Mean ± SD | 6.46 ± 2.72 | 6.76 ± 3.02 | 6.03 ± 2.72 |
| Median ± IQR | 6.50 ± 4.50 | 7 ± 6 | 6 ± 5.25 |
| Cervical dilatation (hour 3) | |||
| Min–max | 0–10 | 0–10 | 2–10 |
| Mean ± SD | 7.58 ± 3.17 | 7.45 ± 3.01 | 6.97 ± 2.66 |
| Median ± IQR | 10 ± 5.50 | 10 ± 5 | 7.50 ± 5 |
| Cervical dilatation (hour 4) | |||
| Min–max | 0–10 | 0–10 | 2–10 |
| Mean ± SD | 7.96 ± 3.04 | 7.90 ± 2.48 | 7.77 ± 2.62 |
| Median ± IQR | 10 ± 4 | 10 ± 5 | 9 ± 4 |
| Duration of the stage of labour | |||
| First stage | |||
| Min–max | 10–660 | 30–650 | 30–1320 |
| Mean ± SD | 210.14 ± 177.13 | 224.43 ± 157.25 | 362.46 ± 292.12 |
| Median ± IQR | 170 ± 310 | 180 ± 216.25 | 262.50 ± 333.75 |
| Second stage | |||
| Min–max | 3–99 | 1–60 | 4–120 |
| Mean ± SD | 23.59 ± 23.73 | 20.50 ± 13.94 | 31.17 ± 27.25 |
| Median ± IQR | 17.50 ± 25.75 | 21.50 ± 20.75 | 23.75 ± 35.88 |
| Third stage | |||
| Min–max | 1–20 | 1–10 | 1–7 |
| Mean ± SD | 5.45 ± 4.50 | 5.50 ± 3.10 | 2.17 ± 1.50 |
| Median ± IQR | 4 ± 6 | 5 ± 8 | 2 ± 2 |
| Membrane rupture | |||
| Min–max | 2–33 | 0.50–12.0 | 0.00 |
| Mean ± SD | 9.50 ± 9.79 | 4.38 ± 3.96 | 0.00 |
| Median ± IQR | 6.0 ± 9.0 | 2.50 ± 6.50 | 0.00 |
| Uterine contractions | |||
| Min–max | 0–370 | 0–590 | 0–660 |
| Mean ± SD | 103.20 ± 123.42 | 168.05 ± 145.58 | 172.26 ± 169.10 |
| Median ± IQR | 50 ± 110 | 142.50 ± 215.0 | 120.0 ± 141.0 |
| Estimated blood loss amount (ml) | |||
| Min–max | 100–600 | 75–600 | 100–600 |
| Mean ± SD | 302.27 ± 126.75 | 297.20 ± 130.78 | 287.50 ± 157.2 |
| Median ± IQR | 300 ± 212.50 | 300 ± 200 | 212.50 ± 237.5 |
| APGAR score at 1 min | |||
| Min–Max | 1–9 | 5–10 | 4–9 |
| Mean ± SD | 7.77 ± 2.02 | 8.59 ± 1.02 | 8.25 ± 1.14 |
| Median ± IQR | 9 ± 3 | 9 ± 0.50 | 9 ± 1 |
| APGAR score at 5 min | |||
| Min–max | 5–10 | 8–10 | 8–10 |
| Mean ± SD | 9.20 ± 1.36 | 9.88 ± 0.44 | 9.57 ± 0.59 |
| Median ± IQR | 10 ± 1 | 10 ± 0.0 | 10 ± 1.0 |
APGAR, Appearance, Pulse, Grimace, Activity, and Respiration.
Labour outcomes and foetal well-being factors.
| Factors | Frequency (n) | Percentage (%) |
|---|---|---|
| Spontaneous vaginal delivery | 40 | 48.19 |
| Transfer to an obstetric unit | 1 | 1.21 |
| Regional analgesia (epidural and/or spinal) | 0 | 0 |
| Episiotomy | 33 | 39.76 |
| Caesarean delivery | 4 | 4.82 |
| Instrumental delivery (forceps or ventouse) | 3 | 3.61 |
| Complete placental delivery | 78 | 100 |
| Incomplete placental delivery | 0 | 0 |
| Normal foetal presentation | 84 | 98.82 |
| Meconium- or blood-stained liquor | 27 | 31.77 |
| Normal foetal heart rate | 58 | 74.36 |
| Presence of caput | 24 | 31.17 |
Maternal outcome factors.
| Factors | Statistical value* | |
|---|---|---|
| Cervical dilatation | 0.53 | 0.588 |
| Stage of labour | ||
| Stage 1 | 3.93 | 0.024 |
| Stage 2 | 1.71 | 0.188 |
| Stage 3 | 8.64 | <0.001 |
| Rupture of membrane | 1.12 | 0.333 |
| Uterine contraction strength | 3.89** | 0.421 |
| Uterine contraction frequency | 3.02 | 0.072 |
| Uterine contraction regularity | 0.85** | 0.654 |
| Tocometric findings | 5.06** | 0.079 |
| Maternal progression factors | 10.55** | 0.394 |
| Estimated blood loss amount | 0.070** | 0.932 |
*ANOVA, **chi square test.
Foetal well-being factors.
| Factors | Statistical value* | |
|---|---|---|
| Foetal presentation | 2.73** | 0.256 |
| Liquor | 7.11** | 0.029 |
| Foetal heart rate | 13.99** | 0.030 |
| Caput | 6.78** | 0.034 |
| APGAR score (1 min) | 2.10 | 0.130 |
| APGAR score (5 min) | 3.52 | 0.035 |
*ANOVA, **chi square test.
APGAR, Appearance, Pulse, Grimace, Activity, and Respiration.